Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The purpose of the study is to determine whether a p38 kinase inhibitor reduces inflammation in atherosclerotic plaque
Epistemonikos ID: 2cff1fd0be789d847c49fac1376501bda37c4ba1
First added on: May 04, 2024